NATALIZUMAB DISCONTINUATION IN PATIENTS DIAGNOSED WITH RELAPSING REMITTING MULTIPLE SCLEROSIS
PS-017
CORRECTIVE ACTIONS AFTER PARTICIPATING IN THE STUDY MULTICENTRE WATCHING FOR DETECTION OF MEDICATION ERRORS (EMOPEM)
PS-016
MEDICATION SAFETY IN NEONATAL CARE: ANALYSIS OF HIGH-ALERT MEDICATIONS
PS-015
THE DEVELOPMENT OF A VIDEO TO DEMONSTRATE EXTEMPORANEOUS EYE DROP PREPARATION FOR USE BY COMMUNITY PHARMACISTS
PS-014
AN OBSERVATIONAL REVIEW AND AUDIT OF THE TREATMENT OF HYPOGLYCAEMIC EVENTS IN A UNIVERSITY TEACHING HOSPITAL
PS-013
MULTICENTER STUDY OF ENVIRONMENTAL CONTAMINATION WITH CYCLOPHOSPHAMIDE, IFOSFAMIDE AND METHOTREXATE IN 66 CANADIAN HOSPITALS: 2016 FOLLOW-UP STUDY
PS-012
SURFACE CONTAMINATION IN A TEACHING HOSPITAL: A 6-YEAR PERSPECTIVE
PS-010
EVALUATION OF A CLINICAL DECISION SUPPORT SYSTEM (CDSS) TO OPTIMIZE CYTOTOXIC DRUG DOSING AND CONTINUOUS SURVEILLANCE IN OUTPATIENT CANCER PATIENTS WITH RENAL IMPAIRMENT
PS-006
ANALYSIS OF DRUG RELATED PROBLEMS AND PHARMACIST’S RECOMENDATION OF HOSPITALISED PATIENTS WITH CHRONIC KIDNEY DISEASE AT A MAJOR TEACHING HOSPITAL IN JAKARTA